Oracle Mining Corp. Oracle Mining closes investment

New Post Public Reply Private Reply Replies (0) Message Board
testuser
Oracle Mining Corp. Oracle Mining closes investment agreement and enters into offtake agreement MF2 makes equity investment of $8.3 millionMF2 acquires 3% Net Smelter Royalty for US$10 million MF2 agrees to purchase 100% of the mineral offtake from Oracle Ridge Vancouver, British Columbia, November 21, 2012 - Oracle Mining Corp. ("Oracle Mining" or the "Corporation") (TSX: OMN, OTCQX: OMCCF, FRANKFURT: OMC) is pleased to announce that it has completed a private placement (the "Private Placement") of 9.8 million units of the Corporation (the "Units") with MF2 Investment Company 1 LP ("MF2"), an affiliate of RK Mine Finance (Master) Fund II LP ("RKMF").  Each Unit consists of one common share of the Corporation (each, a "Common Share") and one-half one common share purchase warrant (each whole warrant, a "Warrant") at a subscription price of $0.85 per Unit.  Each Warrant entitles MF2 to acquire a Common Share at a price of $1.02 per Common Share for a period of 36 months from the date of issue. In connection with the Private Placement, the Corporation, Oracle Ridge Mining, LLC, a wholly-owned subsidiary of the Corporation, and MF2 amended the previously announced investment agreement among the parties dated November 2, 2012 (the "Investment Agreement").  Pursuant to the amended Investment Agreement, MF2 purchased the Units pursuant to the Private Placement rather than as the lead order under the Corporation's offering by way of short form prospectus (the "Prospectus") dated November 9, 2012 (the "Prospectus Offering"). As a result of the Private Placement, MF2 has become an insider of the Corporation, owning approximately 19.99% of the issued and outstanding Common Shares.  Based on the issued and outstanding Common Shares prior to giving effect to the Private Placement: (i) the 9.8 million Common Shares acquired by MF2 represented approximately 24.9% of the Common Shares; (ii) the 4.9 million Warrants, on exercise, represented approximately 12.5% of the Common Shares; and (iii) on a post exercise basis, MF2's ownership would increase to 14.7 million Common Shares (the "Maximum Issuable Securities"), which would have represented approximately 38% of the Common Shares previously outstanding. The Toronto Stock Exchange (the "TSX") has conditionally approved the Private Placement, and the Corporation expects to receive final acceptance from the TSX upon satisfaction of customary post-closing filing requirements.  Pursuant to Section 604(d) of the TSX Company Manual, the Corporation obtained written evidence from holders of more than 50% of the Common Shares that they are in favour of the Private Placement because:  (i) the Private Placement may result in the issuance of an excess of 25% of the issued and outstanding Common Shares prior to giving effect to the Private Placement, and (ii) the Maximum Issuable Securities represent approximately 27% of the currently issued and outstanding Common Shares on a partially-diluted basis on completion of the Private Placement, which, in accordance with the rules and policies of the TSX, could materially affect control of the Corporation.   In accordance with the terms of the Investment Agreement, MF2 has also purchased a 3% Net Smelter Returns Royalty (the "NSR") on the future sale of any metals and minerals derived from the Oracle Ridge Copper Mine in Arizona, USA, for a gross purchase price of US$10 million. These proceeds are being held in escrow pending the registration of certain documentation in connection with the NSR. In addition, Oracle Ridge and MF2 entered into an offtake agreement which provides that MF2 will purchase 100% of the Oracle Ridge Copper Mine’s future annual copper concentrate production for the life of the mine. The price payable for the material is to be based on prices set by the London Metal Exchange as published by the London Metal Bulletin.   Pursuant to the terms of the Investment Agreement, the Corporation appointed Mr. Douglas Silver to the Oracle Mining board of directors as MF2's nominee.  “RKMF is a top-tier mining finance house and we are pleased to have RKMF’s support as an investor and concentrate buyer but also as a partner as we advance the Oracle Ridge Copper Mine,” said  Mr. Paul Eagland, Oracle Mining’s Chairman. “Oracle Mining appreciates the great efforts that have gone in to completing our transactions with RKMF and gives a warm welcome to Mr. Douglas Silver as he joins the Oracle Mining board.”  Oracle Mining shall use the net proceeds from the Private Placement and the sale of the NSR towards the continued development of its Oracle Ridge Copper Mine and for related working capital requirements.  All securities distributed pursuant to the Private Placement will be subject to a hold period of four months following closing in accordance with applicable Canadian securities laws and such other further restrictions as may apply under foreign securities laws.  In accordance with the rules and policies of the TSX, the Warrants are not exercisable until five business days after the date of this news release.  In accordance with the terms of the Corporation’s rights plan, the board has suspended the application thereof with respect to the Private Placement. The Company also announced that it intends to proceed with the Prospectus Offering depending upon market conditions.  The Prospectus Offering is currently expected to close on or about November 30, 2012. This media release is intended for distribution in Canada only and is not intended for distribution to United States newswire services or dissemination in the United States. The Shares will not be offered or sold in the United States or to, or for the account of, United States persons except to accredited investors pursuant to the exemption from the registration requirements contained under the United States Securities Act of 1933, as amended, to deal with the possibility that the Shares may be sold to United States persons. About Oracle Mining Corp. Oracle Mining Corp. (TSX: OMN, OTCQX: OMCCF, FRANKFURT: OMC) is a Vancouver, Canada-based corporation that is the sole owner and operator of Oracle Ridge Mining LLC and the Oracle Ridge Copper Mine located 24 km northeast of Tucson, Arizona. Oracle Mining is managed by an experienced team of mining professionals with extensive operating and financial experience.  Forward-looking Statement DisclaimerThis document may contain "forward-looking statements" within the meaning of Canadian securities legislation. These forward-looking statements are made as of the date of this document and Oracle Mining Corp. (hereinafter referred to as the "Corporation") does not intend, and does not assume any obligation, to update these forward-looking statements. Forward-looking statements relate to future events or future performance and reflect management of the Corporation’s expectations or beliefs regarding future events and include, but are not limited to, statements with respect to the expected completion of the Prospectus Offering; the intended use of proceeds from the Private Placement; the exercise of Warrants by MF2 and the purchase by MF2 of the Oracle Ridge Copper Mine's future annual copper concentrate. In certain cases, forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative of these terms or comparable terminology. By their very nature forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Corporation to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, risks related to the Corporation's ability to obtain final exchange approval of the Private Placement or the transactions contemplated with MF2; risks related to the completion of the Prospectus Offering in the expected time frame or at all, including the exercise by the Agents of their termination rights under the agency agreement; risks related to changes in the market; actual results of current exploration activities; changes in project parameters as plans continue to be refined; future prices of resources; accidents, labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing or in the completion of development or construction activities; as well as those factors detailed from time to time in the Corporation’s interim and annual financial statements and management's discussion and analysis of those statements, all of which are filed and available for review on SEDAR at www.sedar.com. Although the Corporation has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.  For further information, contact: Mr. Carlos Escribano, CFOT: 604-689-9282 Toll-free: +1-855-689-9282ORMr. Jason Mercier, VP Corporate SecretaryT: 604-689-9261E: info@oracleminingcorp.comwww.oracleminingcorp.com
Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading